First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters

Ultrasound in Obstetrics and Gynecology

Volumn 27, Issue 2, 2006, Pages 156-161

  Leung, T Y ^a,b   Chan, L W ^a   Leung, T N ^a   Fung, T Y ^a   Sahota, D S ^a   Lau, T K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Fetal biometry; Fetal growth; Free beta human chorionic gonadotropin; Prediction; Pregnancy associated plasma protein A

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTAL PEPTIDE HORMONE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BIOMETRY; BIPARIETAL DISTANCE; BODY HEIGHT; BODY WEIGHT; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; CROWN RUMP LENGTH; DOWN SYNDROME; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES;

EID: 33646689085     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.2656     Document Type: Article

References (32)

1. M Kady S, Gardosi J. Perinatal mortality and fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2004; 18: 397-410.
2. Gluckman PD, Liggins GC. Regulation of fetal growth. In Fetal Physiology and Medicine, Beard RW, Nathanielsz PW (eds). Dekker: New York, NY, 1992; 511-558.
3. Smith GC. First trimester origins of fetal growth impairment. Semin Perinatol 2004; 28: 41-50.
4. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767.
5. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Am J Obstet Gynecol 2004; 191: 1452-1458.
6. Bischof P, DuBerg S, Herrmann W, Sizonenko PC. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol 1981; 88: 973-975.
7. Smith GCS, Smith MFS, McNay MB, Fleming JEE. First-trimester growth and the risk of low birth weight. N Engl J Med 1998; 339: 1817-1822.
8. Mazerbourg S, Callebaut I, Zapf J, Mohan S, Overgaard M, Monget P. Update on IGFBP-4: regulation of IGFBP-4 levels and functions, in vitro and in vivo. Growth Horm IGF Res 2004; 14: 71-84.
9. Han VK, Matsell DG, Delhanty PJ, Hill DJ, Shimasaki S, Nygard K. IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Horm Res 1996; 45: 160-166.
10. Leung TY, Spencer K, Leung TN, Fung TY, Lau TK. The Chinese ethnic group has a higher median level of free β-hCG and PAPP-A - implication on first trimester combined screening of Down syndrome in the Chinese population. Fetal Diagn Ther 2006; 21: 140-143.
11. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z. Predicting complications of pregnancy with first-trimester maternal serum free-beta hCG, PAPP-A and inhibin-A. Prenat Diagn 2003; 23: 990-996.
12. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates 3rd JR, Conover CA. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci 1999; 96: 3149-3153.
13. Monget P, Mazerbourg S, Delpuech T, Maurel MC, Maniere S, Zapf J, Lalmanach G, Oxvig C, Overgaard MT. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod 2003; 68: 77-86.
14. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 2001; 504: 36-40.
15. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 1998; 140: 19-24.
16. Bunn RC, Green LD, Overgaard MT, Oxvig C, Fowlkes JL. IGFBP-4 degradation by pregnancy-associated plasma protein-A in MC3T3 osteoblasts. Biochem Biophys Res Commun 2004; 325: 698-706.
17. Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 2001; 142: 2641-2648.
18. Qin X, Byun D, Lau KH, Baylink DJ, Mohan S. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. Arch Biochem Biophys 2000; 379: 209-216.
19. Ortiz CO, Chen BK, Bale LK, Overgaard MT, Oxvig C, Conover CA. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 2003; 18: 1066-1072.
20. Roghani M, Lassarre C, Zapf J, Povoa G, Binoux M. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J Clin Endocrinol Metab 1991; 73: 658-666.
21. Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 1998; 18: 147-152.
22. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107: 1265-1270.
23. Benn PA, Home D, Briganti S, Rodis JF, Clive JM. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol 1996; 87: 217-222.
24. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992; 80: 83-86.
25. Palacio M, Jauniaux E, Kingdom J, Dell E, Sheldrake A, Rodeck CH. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol 1999; 13: 58-62.
26. Hsieh TT, Hung TH, Hsu JJ, Shau WY, Su CW, Hsieh FJ. Prediction of adverse perinatal outcome by maternal serum screening for Down's syndrome in an Asian population. Obstet Gynecol 1997; 89: 937-940.
27. Miyakoshi K, Tanaka M, Gabionza D, Ishimoto H, Miyazaki T, Yoshimura Y. Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study. Fetal Diagn Ther 2001; 16: 42-46.
28. Muller F, Savey L, Le Fiblec B, Bussieres L, Ndayizamba G, Colau JC, Giraudet P. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996; 175: 37-40.
29. Blundell G, Ashby JP, Martin C, Shearing CH, Langdale-Brown B, Keeling J, Ellis PM, Shade M, Chambers SE, Wenham PR. Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies. Prenat Diagn 1999; 19: 219-223.
30. Vintzileos AM, Campbell WA, Guzman ER, Smulian JC, McLean DA, Ananth CV. Second-trimester ultrasound markers for detection of trisomy 21: which markers are best? Obstet Gynecol 1997; 89: 941-944.
31. Vintzileos AM, Egan JF, Smulian JC, Campbell WA, Guzman ER, Rodis JF. Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry. Obstet Gynecol 1996; 87: 953-958.
32. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Williams MA. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol 1993; 168: 534-538.